LCID
Lucid Group, Inc.
LCID lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
MNSO
MINISO Group Holding Limited
There isn't enough reported data to score MNSO yet.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
MNSO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Stable | |
| Strong |
MNSO's revenue and balance sheet are currently healthy, and its profitability and cash flow are stable.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
MNSO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $9.54 | -13% |
| Current | 18x | $10.94 | — |
| Fair | 20x | $12.49 | +14% |
| Expensive | 49x | $29.81 | +173% |
Historical ranges are pointers, not guarantees.
MNSO's PE is 18x, but its earnings don't support one, so it isn't a reliable read right now.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
MNSO Forward outlook
There aren't enough analyst estimates for MNSO to show an outlook.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
MNSO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $0.61 | -46% |
| Q1 2026 | $0.99 | -16% |
| Q4 2025 | $0.58 | -54% |
| Q3 2025 | $1.04 | -12% |
| Q2 2025 | $1.13 | -2.6% |
| Q1 2025 | $1.18 | +3.5% |
| Q4 2024 | $1.26 | +19% |
| Q3 2024 | $1.18 | +40% |
MNSO has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over MNSO on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
MNSO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $869.5M | +17% |
| Q1 2026 | $848.5M | +28% |
| Q4 2025 | $925.6M | +31% |
| Q3 2025 | $869.9M | +28% |
| Q2 2025 | $745.3M | +23% |
| Q1 2025 | $664.4M | +19% |
| Q4 2024 | $707.2M | +23% |
| Q3 2024 | $678.7M | +19% |
MNSO's revenue has grown year over year for 14 quarters in a row: $870M last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 13% | -2.8 points |
| Q1 2026 | 12% | -3.4 points |
| Q4 2025 | 14% | -6.6 points |
| Q3 2025 | 14% | -4 points |
| Q2 2025 | 16% | -2.9 points |
| Q1 2025 | 16% | -4.4 points |
| Q4 2024 | 20% | +0.4 points |
| Q3 2024 | 18% | -2.8 points |
MNSO has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has the stronger cash trend. Its trailing FCF is down 75% versus its history, compared with MNSO at down 100%.
MNSO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | $0 |
| Q3 2025 | $0 | $0 |
| Q2 2025 | $0 | $0 |
| Q1 2025 | $0 | $0 |
| Q4 2024 | $0 | $0 |
| Q3 2024 | $0 | $0 |
| Q2 2024 | $0 | $0 |
MNSO's free cash flow was $0 over the past year, against $0 the year before.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
MNSO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1% | +3.1M shares |
| 1 year | +0.1% | +218K shares |
| 3 years | -1.2% | -3.9M shares |
| 5 years | +6.6% | +19.3M shares |
| Available history | -1.3% | -4.2M shares |
MNSO has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MNSO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | 1.6x | Healthy |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 2.5x | Moderate |
| Q2 2025 | 1.0x | Very low |
| Q1 2025 | 0.7x | Very low |
| Q4 2024 | -0.9x | Net Cash |
| Q3 2024 | 0.1x | Very low |
MNSO's net debt is less than a year of its operating earnings (EBITDA).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
MNSO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.6 | Neutral |
| Stochastic | 50.4 | Neutral |
MNSO's weekly RSI is 45 (neutral) and its Stochastic is 50 (neutral).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
MNSO PE vs Consumer Cyclical Sector
| Metric | MNSO | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.1% above |
| PE % | 34 | 48 | 14 pts below |
MNSO is trading at 18x earnings, in line with the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
MNSO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.96 | 9.8% above |
| 20 week MA | $10.7 | 2.2% above |
| 50 week MA | $14.3 | 23% below |
| 100 week MA | $17.5 | 37% below |
| 200 week MA | $18.6 | 41% below |
MNSO has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
MNSO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $23.2 | $31.0 | +34% |
| 2021 | $31.0 | $10.1 | -68% |
| 2022 | $10.1 | $11.3 | +12% |
| 2023 | $11.3 | $20.4 | +81% |
| 2024 | $20.4 | $24.1 | +18% |
| 2025 | $24.1 | $19.6 | -18% |
| 2026 YTD | $19.6 | $10.9 | -44% |
MNSO has the edge over LCID on returns for 2026, with the stronger performance.